EDISON, NEW JERSEY
“Strong potential” has been reported for a product developed by PolarityTE for “flawless healing” of burnt tissue. SkinTE grows a biopsy of a patient’s own skin to uniformly cover an area 500-1000 times its size, without scarring. The new skin matches the patient’s own and is fully functional, with the dermis, epidermis, and hair appendages. The process has fared well in experiments on animals; and the first test on a human, in which a 30-in2 scar was removed and replaced with SkinTE, was declared a success halfway through the healing process. The results of a case study should be available mid-year. PolarityTE estimates SkinTE could generate $600 million by 2023, with peak market penetration at 85,000 wounds. The company has other products for tissue regeneration that could boost its net worth to $1.7 billion. OsteoTE could be commercialized by the end of the year, and treatments for cartilage, heart muscle, and hair replacement are in various stages of study. On a sobering note, Seeking Alpha reports that, while PolarityTE has acquired the skin regeneration patent for $104.7 million, SkinTE is but the latest in a chain of products, including video games, to be offered by a company marked by failed investments. However, the jury is still out on whether the company is viable in the long term, as this report titled “Investors, Beware” suggests.